vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and PEAPACK GLADSTONE FINANCIAL CORP (PGC). Click either name above to swap in a different company.
PEAPACK GLADSTONE FINANCIAL CORP is the larger business by last-quarter revenue ($78.2M vs $44.9M, roughly 1.7× AbCellera Biologics Inc.). PEAPACK GLADSTONE FINANCIAL CORP runs the higher net margin — 15.5% vs -19.9%, a 35.5% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 26.5%). PEAPACK GLADSTONE FINANCIAL CORP produced more free cash flow last quarter ($28.8M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 21.4%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Peapack Gladstone Financial Corp is a U.S.-based regional financial holding company that provides commercial and consumer banking, wealth management, private banking, lending solutions, and trust services, primarily serving individual and small-to-medium business clients across New Jersey and the surrounding U.S. Northeast region.
ABCL vs PGC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $78.2M |
| Net Profit | $-8.9M | $12.2M |
| Gross Margin | — | — |
| Operating Margin | -63.7% | 21.7% |
| Net Margin | -19.9% | 15.5% |
| Revenue YoY | 788.4% | 26.5% |
| Net Profit YoY | 73.9% | 31.6% |
| EPS (diluted) | $-0.03 | $0.68 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $78.2M | ||
| Q3 25 | $9.0M | $70.7M | ||
| Q2 25 | $17.1M | $69.7M | ||
| Q1 25 | $4.2M | $64.4M | ||
| Q4 24 | $5.0M | $61.8M | ||
| Q3 24 | $6.5M | $56.6M | ||
| Q2 24 | $7.3M | $56.6M | ||
| Q1 24 | $10.0M | $53.1M |
| Q4 25 | $-8.9M | $12.2M | ||
| Q3 25 | $-57.1M | $9.6M | ||
| Q2 25 | $-34.7M | $7.9M | ||
| Q1 25 | $-45.6M | $7.6M | ||
| Q4 24 | — | $9.2M | ||
| Q3 24 | $-51.1M | $7.6M | ||
| Q2 24 | $-36.9M | $7.5M | ||
| Q1 24 | $-40.6M | $8.6M |
| Q4 25 | -63.7% | 21.7% | ||
| Q3 25 | -851.8% | 19.2% | ||
| Q2 25 | -290.2% | 16.1% | ||
| Q1 25 | -1479.6% | 16.2% | ||
| Q4 24 | — | 19.8% | ||
| Q3 24 | -1439.4% | 19.0% | ||
| Q2 24 | -1276.2% | 16.9% | ||
| Q1 24 | -551.5% | 23.4% |
| Q4 25 | -19.9% | 15.5% | ||
| Q3 25 | -637.8% | 13.6% | ||
| Q2 25 | -203.3% | 11.4% | ||
| Q1 25 | -1077.2% | 11.8% | ||
| Q4 24 | — | 14.9% | ||
| Q3 24 | -785.4% | 13.4% | ||
| Q2 24 | -504.3% | 13.3% | ||
| Q1 24 | -408.0% | 16.3% |
| Q4 25 | $-0.03 | $0.68 | ||
| Q3 25 | $-0.19 | $0.54 | ||
| Q2 25 | $-0.12 | $0.45 | ||
| Q1 25 | $-0.15 | $0.43 | ||
| Q4 24 | — | $0.52 | ||
| Q3 24 | $-0.17 | $0.43 | ||
| Q2 24 | $-0.13 | $0.42 | ||
| Q1 24 | $-0.14 | $0.48 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $658.2M |
| Total Assets | $1.4B | $7.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | — | ||
| Q3 25 | $83.2M | — | ||
| Q2 25 | $92.4M | — | ||
| Q1 25 | $159.3M | — | ||
| Q4 24 | $156.3M | — | ||
| Q3 24 | $126.6M | — | ||
| Q2 24 | $148.3M | — | ||
| Q1 24 | $123.6M | — |
| Q4 25 | $966.9M | $658.2M | ||
| Q3 25 | $964.0M | $642.5M | ||
| Q2 25 | $1.0B | $629.8M | ||
| Q1 25 | $1.0B | $621.9M | ||
| Q4 24 | $1.1B | $605.8M | ||
| Q3 24 | $1.1B | $607.6M | ||
| Q2 24 | $1.1B | $588.3M | ||
| Q1 24 | $1.1B | $582.4M |
| Q4 25 | $1.4B | $7.5B | ||
| Q3 25 | $1.4B | $7.4B | ||
| Q2 25 | $1.4B | $7.2B | ||
| Q1 25 | $1.3B | $7.1B | ||
| Q4 24 | $1.4B | $7.0B | ||
| Q3 24 | $1.4B | $6.8B | ||
| Q2 24 | $1.4B | $6.5B | ||
| Q1 24 | $1.5B | $6.4B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $43.1M |
| Free Cash FlowOCF − Capex | $-44.6M | $28.8M |
| FCF MarginFCF / Revenue | -99.4% | 36.8% |
| Capex IntensityCapex / Revenue | 21.9% | 18.3% |
| Cash ConversionOCF / Net Profit | — | 3.55× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $61.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $43.1M | ||
| Q3 25 | $-52.6M | $36.2M | ||
| Q2 25 | $-32.4M | $15.9M | ||
| Q1 25 | $-11.6M | $-7.9M | ||
| Q4 24 | $-108.6M | $71.1M | ||
| Q3 24 | $-28.9M | $24.7M | ||
| Q2 24 | $-30.0M | $852.0K | ||
| Q1 24 | $-41.7M | $19.1M |
| Q4 25 | $-44.6M | $28.8M | ||
| Q3 25 | $-61.5M | $34.0M | ||
| Q2 25 | $-45.8M | $9.9M | ||
| Q1 25 | $-22.2M | $-11.5M | ||
| Q4 24 | $-187.0M | $63.0M | ||
| Q3 24 | $-47.4M | $23.0M | ||
| Q2 24 | $-50.1M | $-431.0K | ||
| Q1 24 | $-65.8M | $18.0M |
| Q4 25 | -99.4% | 36.8% | ||
| Q3 25 | -687.0% | 48.1% | ||
| Q2 25 | -267.9% | 14.2% | ||
| Q1 25 | -524.0% | -17.8% | ||
| Q4 24 | -3702.8% | 101.9% | ||
| Q3 24 | -728.4% | 40.6% | ||
| Q2 24 | -683.8% | -0.8% | ||
| Q1 24 | -661.5% | 33.9% |
| Q4 25 | 21.9% | 18.3% | ||
| Q3 25 | 99.7% | 3.1% | ||
| Q2 25 | 78.2% | 8.6% | ||
| Q1 25 | 251.1% | 5.6% | ||
| Q4 24 | 1552.7% | 13.1% | ||
| Q3 24 | 284.6% | 3.0% | ||
| Q2 24 | 274.6% | 2.3% | ||
| Q1 24 | 242.5% | 2.1% |
| Q4 25 | — | 3.55× | ||
| Q3 25 | — | 3.76× | ||
| Q2 25 | — | 2.01× | ||
| Q1 25 | — | -1.04× | ||
| Q4 24 | — | 7.70× | ||
| Q3 24 | — | 3.25× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 2.21× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABCL
Segment breakdown not available.
PGC
| Banking Segment | $61.4M | 79% |
| Wealth Management Division | $13.9M | 18% |
| Other | $2.9M | 4% |
